Nutraceutical Boom in Cancer: Inside the Labyrinth of Reactive Oxygen Species

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Mar 18

PMID 32178382

Citations 24

Authors

Maura Calvani

Amada Pasha

Claudio Favre

Affiliations

Soon will be listed here.

Abstract

In recent years, epidemiological studies have shown that food is a very powerful means for maintaining a state of well-being and for health prevention. Many degenerative, autoimmune and neoplastic diseases are related to nutrition and the nutrient-organism interaction could define the balance between health and disease. Nutrients and dietary components influence epigenetic phenomena and modify drugs response; therefore, these food-host interactions can influence the individual predisposition to disease and its potential therapeutic response. Do nutraceuticals have positive or negative effects during chemotherapy? The use of nutraceutical supplements in cancer patients is a controversial debate without a definitive conclusion to date. During cancer treatment, patients take nutraceuticals to alleviate drug toxicity and improve long-term results. Some nutraceuticals may potentiate the effect of cytotoxic chemotherapy by inducing cell growth arrest, cell differentiation, and alteration of the redox state of cells, but in some cases, high levels of them may interfere with the effectiveness of chemotherapy, making cancer cells less reactive to chemotherapy. In this review, we highlighted the emerging opinions and data on the pros and cons on the use of nutraceutical supplements during chemotherapy.

Citing Articles

A comparative study on antioxidant properties, total phenolics, total flavonoid contents, and cytotoxic properties of marine green microalgae and diatoms.

Ferdous U, Nurdin A, Ismail S, Shaari K, Norhana Balia Yusof Z J Genet Eng Biotechnol. 2025; 23(1):100456.

PMID: 40074430 PMC: 11795137. DOI: 10.1016/j.jgeb.2024.100456.

Therapeutic controversies over use of antioxidant supplements during cancer treatment: a scoping review.

Woldeselassie M, Tamene A Front Nutr. 2024; 11:1480780.

PMID: 39717397 PMC: 11663640. DOI: 10.3389/fnut.2024.1480780.

Cellular and molecular aspects of drug resistance in cancers.

Shaik R, Malik M, Basavaraju S, Qurban J, Al-Subhi F, Badampudi S Daru. 2024; 33(1):4.

PMID: 39652186 PMC: 11628481. DOI: 10.1007/s40199-024-00545-8.

Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.

Duraj T, Kalamian M, Zuccoli G, Maroon J, DAgostino D, Scheck A BMC Med. 2024; 22(1):578.

PMID: 39639257 PMC: 11622503. DOI: 10.1186/s12916-024-03775-4.

Pharmacodynamics and safety in relation to dose and response of plant flavonoids in treatment of cancers.

Vazhappilly C, Alsawaf S, Mathew S, Nasar N, Hussain M, Cherkaoui N Inflammopharmacology. 2024; 33(1):11-47.

PMID: 39580755 DOI: 10.1007/s10787-024-01581-1.

References

Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D . Oxidative stress, aging, and diseases. Clin Interv Aging. 2018; 13:757-772. PMC: 5927356. DOI: 10.2147/CIA.S158513. View

Zhao H, Zhu H, Huang J, Zhu Y, Hong M, Zhu H . The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leuk Res. 2018; 66:1-7. DOI: 10.1016/j.leukres.2017.12.009. View

Hardy G . Nutraceuticals and functional foods: introduction and meaning. Nutrition. 2000; 16(7-8):688-9. DOI: 10.1016/s0899-9007(00)00332-4. View

Celano M, Rosignolo F, Maggisano V, Pecce V, Iannone M, Russo D . MicroRNAs as Biomarkers in Thyroid Carcinoma. Int J Genomics. 2017; 2017:6496570. PMC: 5606057. DOI: 10.1155/2017/6496570. View

Vargas-Mendoza N, Morales-Gonzalez A, Madrigal-Santillan E, Madrigal-Bujaidar E, Alvarez-Gonzalez I, Garcia-Melo L . Antioxidant and Adaptative Response Mediated by Nrf2 during Physical Exercise. Antioxidants (Basel). 2019; 8(6). PMC: 6617290. DOI: 10.3390/antiox8060196. View

Han G, Xia J, Gao J, Inagaki Y, Tang W, Kokudo N . Anti-tumor effects and cellular mechanisms of resveratrol. Drug Discov Ther. 2015; 9(1):1-12. DOI: 10.5582/ddt.2015.01007. View

McCubrey J, Lertpiriyapong K, Steelman L, Abrams S, Yang L, Murata R . Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY). 2017; 9(6):1477-1536. PMC: 5509453. DOI: 10.18632/aging.101250. View

Chen X, Hu Z, Yang X, Huang M, Gao Y, Tang W . Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. Int Immunopharmacol. 2006; 6(3):499-508. DOI: 10.1016/j.intimp.2005.08.026. View

Das L, Vinayak M . Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer. PLoS One. 2015; 10(4):e0124000. PMC: 4393109. DOI: 10.1371/journal.pone.0124000. View

10.

Hardy T, Tollefsbol T . Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011; 3(4):503-18. PMC: 3197720. DOI: 10.2217/epi.11.71. View

11.

Benzie I . Evolution of antioxidant defence mechanisms. Eur J Nutr. 2000; 39(2):53-61. DOI: 10.1007/s003940070030. View

12.

Lichner Z, Fendler A, Saleh C, Nasser A, Boles D, Al-Haddad S . MicroRNA signature helps distinguish early from late biochemical failure in prostate cancer. Clin Chem. 2013; 59(11):1595-603. DOI: 10.1373/clinchem.2013.205450. View

13.

Strogantsev R, Ferguson-Smith A . Proteins involved in establishment and maintenance of imprinted methylation marks. Brief Funct Genomics. 2012; 11(3):227-39. DOI: 10.1093/bfgp/els018. View

14.

Song J, Lee K, Seong B . Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005; 68(2):66-74. DOI: 10.1016/j.antiviral.2005.06.010. View

15.

Al-Sharif I, Remmal A, Aboussekhra A . Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation. BMC Cancer. 2013; 13:600. PMC: 3931838. DOI: 10.1186/1471-2407-13-600. View

16.

Nosrati N, Bakovic M, Paliyath G . Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds. Int J Mol Sci. 2017; 18(10). PMC: 5666732. DOI: 10.3390/ijms18102050. View

17.

Dijsselbloem N, Vanden Berghe W, De Naeyer A, Haegeman G . Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol. 2004; 68(6):1171-85. DOI: 10.1016/j.bcp.2004.05.036. View

18.

Newsholme P, Haber E, Hirabara S, Rebelato E, Procopio J, Morgan D . Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol. 2007; 583(Pt 1):9-24. PMC: 2277225. DOI: 10.1113/jphysiol.2007.135871. View

19.

Luo Y, Zha L, Luo L, Chen X, Zhang Q, Gao C . [6]-Gingerol enhances the cisplatin sensitivity of gastric cancer cells through inhibition of proliferation and invasion via PI3K/AKT signaling pathway. Phytother Res. 2019; 33(5):1353-1362. DOI: 10.1002/ptr.6325. View

20.

Villanueva C, Kross R . Antioxidant-induced stress. Int J Mol Sci. 2012; 13(2):2091-2109. PMC: 3292009. DOI: 10.3390/ijms13022091. View